GeneMatrix Inc. (KOSDAQ: 109820)
South Korea
· Delayed Price · Currency is KRW 2,750.00
-45.00 (-1.61%)
Dec 17, 2024, 12:32 PM KST
GeneMatrix Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2013 - 2009 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '19 Sep 30, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | 2013 - 2009 |
| Other Revenue | - | - | - | -0 | - | - | Upgrade
|
| Revenue | 4,722 | 4,735 | 5,189 | 5,080 | 5,315 | 6,676 | Upgrade
|
| Revenue Growth (YoY) | -3.67% | -8.75% | 2.15% | -4.43% | -20.39% | -8.43% | Upgrade
|
| Cost of Revenue | 2,936 | 3,005 | 3,360 | 3,178 | 2,991 | 3,699 | Upgrade
|
| Gross Profit | 1,786 | 1,730 | 1,829 | 1,902 | 2,325 | 2,977 | Upgrade
|
| Selling, General & Admin | 2,231 | 2,106 | 1,454 | 3,783 | 2,058 | 2,283 | Upgrade
|
| Research & Development | 1,895 | 2,163 | 2,005 | 1,896 | 2,066 | 1,740 | Upgrade
|
| Other Operating Expenses | 39.57 | 33.4 | 30.11 | 24.62 | 27.48 | 27.34 | Upgrade
|
| Operating Expenses | 4,415 | 4,536 | 3,591 | 5,883 | 4,492 | 4,299 | Upgrade
|
| Operating Income | -2,629 | -2,806 | -1,762 | -3,981 | -2,168 | -1,322 | Upgrade
|
| Interest Expense | -638.17 | -634.82 | -97.28 | -248.16 | -196.81 | -146.52 | Upgrade
|
| Interest & Investment Income | 272.97 | 239.93 | 133.43 | 159.12 | 132.29 | 171.61 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.86 | 6.5 | -8.54 | 28.4 | 57.08 | 29.49 | Upgrade
|
| Other Non Operating Income (Expenses) | -165.64 | -102.87 | 0.1 | -105.2 | -9.39 | 60.52 | Upgrade
|
| EBT Excluding Unusual Items | -3,156 | -3,298 | -1,735 | -4,146 | -2,184 | -1,207 | Upgrade
|
| Impairment of Goodwill | - | - | - | -86.12 | -222.34 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1,010 | 10.91 | - | -0.01 | 23.04 | 92.57 | Upgrade
|
| Other Unusual Items | -16.72 | - | - | 147.68 | - | - | Upgrade
|
| Pretax Income | -1,970 | -3,287 | -1,735 | -4,085 | -2,384 | -1,114 | Upgrade
|
| Earnings From Continuing Operations | -1,970 | -3,287 | -1,735 | -4,085 | -2,384 | -1,114 | Upgrade
|
| Minority Interest in Earnings | -123.47 | 180.08 | 264.75 | 307.83 | 363.61 | -8.73 | Upgrade
|
| Net Income | -2,093 | -3,107 | -1,470 | -3,777 | -2,020 | -1,123 | Upgrade
|
| Net Income to Common | -2,093 | -3,107 | -1,470 | -3,777 | -2,020 | -1,123 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 15 | 10 | 14 | 13 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 15 | 10 | 14 | 13 | 12 | Upgrade
|
| Shares Change (YoY) | 65.60% | 50.20% | -24.88% | 8.06% | 0.78% | -0.24% | Upgrade
|
| EPS (Basic) | -123.85 | -202.64 | -144.00 | -278.00 | -160.67 | -90.00 | Upgrade
|
| EPS (Diluted) | -123.85 | -202.64 | -144.00 | -278.00 | -160.67 | -90.00 | Upgrade
|
| Free Cash Flow | -2,895 | -3,083 | -1,955 | -644.2 | -670.87 | -1,639 | Upgrade
|
| Free Cash Flow Per Share | -171.28 | -201.08 | -191.59 | -47.41 | -53.36 | -131.37 | Upgrade
|
| Gross Margin | 37.83% | 36.54% | 35.25% | 37.45% | 43.73% | 44.59% | Upgrade
|
| Operating Margin | -55.67% | -59.27% | -33.96% | -78.36% | -40.78% | -19.80% | Upgrade
|
| Profit Margin | -44.33% | -65.61% | -28.32% | -74.35% | -38.01% | -16.82% | Upgrade
|
| Free Cash Flow Margin | -61.31% | -65.10% | -37.68% | -12.68% | -12.62% | -24.55% | Upgrade
|
| EBITDA | -2,144 | -2,461 | -1,433 | -3,593 | -1,660 | -731.56 | Upgrade
|
| EBITDA Margin | -45.41% | -51.98% | -27.61% | -70.74% | -31.23% | -10.96% | Upgrade
|
| D&A For EBITDA | 484.66 | 345.19 | 329.66 | 387.28 | 507.85 | 590.23 | Upgrade
|
| EBIT | -2,629 | -2,806 | -1,762 | -3,981 | -2,168 | -1,322 | Upgrade
|
| EBIT Margin | -55.67% | -59.27% | -33.96% | -78.36% | -40.78% | -19.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.